Status:
NOT_YET_RECRUITING
The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy
Lead Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions:
Esophageal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
1. Research methods Constructed the "Manual for Graded Management of Postoperative Symptoms of Esophageal Cancer" and developed continuous care Procedures. 2. Randomised controlled studies were conduc...
Eligibility Criteria
Inclusion
- The patient is aware and able to communicate in Mandarin;
- There are smartphones；
- Proficient in using WeChat mini programs.
- Patients who were scheduled for esophageal cancer resection in participating centers were eligible for inclusion.
Exclusion
- Have cognitive impairment or psychiatric illness;
- Refusal to participate
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
252 Patients enrolled
Trial Details
Trial ID
NCT07187154
Start Date
October 1 2025
End Date
February 28 2026
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing, China